Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr James Lordan

Newcastle AuthorsTitleYearFull text
Dr James Lordan
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension2024
Dr James Lordan
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension2024
Dr James Lordan
Author Correction: Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood (Nature Communications, (2021), 12, 1, (7104), 10.1038/s41467-021-27326-0)2022
David Stephenson
Dr Daniela Lee
Jill Davison
Dr Stephen Bourke
Professor Anthony De Soyza
et al.		An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation2019
Professor Andrew Fisher
Dr James Lordan
Dr Gerard Meachery
Dr Bart Vanaudenaerde
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe2017
Dr Zheyi Liew
Professor Kate Gould
Dr Su Bunn
Dr Matthew Thomas
Dr James Lordan
et al.		Successful outcome following pneumonectomy in a teenage boy with cystic fibrosis: a case report.2017
Dr James Lordan
Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort2016
Dr Logan Thirugnanasothy
Sasiharan Sithamparanathan
Dr James Lordan
Professor Andrew Fisher
Dr Guy MacGowan
et al.		Establishing The Effect Of Targeted Therapies On Diffusing Capacity In Patients With Pulmonary Arterial Hypertension (PAH)2016
Sasiharan Sithamparanathan
Dr Logan Thirugnanasothy
Professor John Dark
Professor Andrew Fisher
Professor Kate Gould
et al.		Observational study of lung transplant recipients surviving 20 years2016
Sasiharan Sithamparanathan
Dr Logan Thirugnanasothy
Professor Andrew Fisher
Dr James Lordan
Dr Gerard Meachery
et al.		Observational Study of Methotrexate in the Treatment of Bronchiolitis Obliterans Syndrome2016
Dr Gareth Parry
Professor Andrew Fisher
Dr Gerard Meachery
Dr James Lordan
Total Lymphoid Irradiation (TLI) for the Management of Bronchiolitis Obliterans Syndrome (BOS) Post Lung Transplant: A Single Centre Experience2016
Vicky Ryan
Therese Small
Dr James Lordan
Professor Andrew Fisher
Dr Gerard Meachery
et al.		A randomised controlled trial of azithromycin therapy in Bronchiolitis Obliterans Syndrome (BOS) post lung transplantation 2015
Professor Anthony De Soyza
Dr James Lordan
Professor Jeffrey Pearson
Professor Christopher Ward
Azithromycin Attenuates Release Of Bile Acid-Mediated Neutrophilic And Remodeling Factors From Human Bronchial Epithelial Cells2015
Professor Anthony De Soyza
Dr James Lordan
June Pearson
Professor Christopher Ward
Azithromycin Attenuates Release of Bile Acid-Mediated Neutrophilic and Remodelling Factors from Human Bronchial Epithelial Cells2015
Professor Anthony De Soyza
Dr James Lordan
Professor Jeffrey Pearson
Professor Christopher Ward
Bile Acids Cause Direct Inflammation And Injury And Worsen Acid Induced Injury In The Pulmonary Epithelium2015
1234567